SPRO (SPRO) Stock Price & Analysis
SPRO (SPRO) fell 0.82% to USD 1.21 as of September 8, 2026 at 13:27 UTC, according to Nexqual real-time market data.
SPRO last closed at USD 1.21; the session ranged USD 1.19–1.22 on volume of 362,983 shares. Market capitalization is —, with a 52-week range of USD 1.08–3.08 (NMS). Source: Nexqual, September 8, 2026 at 13:27 UTC.
Key Statistics (as of September 8, 2026 at 13:27 UTC)
| Price | USD 1.21 |
|---|---|
| Change | ▼ 0.82% (down) |
| Previous Close | USD 1.21 |
| Open | USD 1.21 |
| Day Range | USD 1.19 – 1.22 |
| 52-Week Range | USD 1.08 – 3.08 |
| Volume | 362,983 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SPRO)
Nexqual's technical model rates SPRO "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 13:27 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.98 (neutral) |
| vs SMA50 | Below (USD 1.47) |
| MACD | -0.06 (negative) |
From SPRO's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| DTIL | Precision BioSciences, Inc. | USD 7.47 | ▲ 0.27% |
| GOSS | Gossamer Bio, Inc. | USD 0.18 | ▲ 1.33% |
| ALEC | Alector, Inc. | USD 2.46 | ▼ 9.56% |
| BDTX | Black Diamond Therapeutics, Inc | USD 2.12 | ▼ 0.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:27 UTC. This page is informational and not investment advice.